Sophie Olivier
Chief Medical Officer
clinical development
Lysogene
France
Biography
Sophie Olivier is responsible for clinical development. A physician by background, Sophie Olivier has extensive clinical development experience in large and small pharma organizations and has overseen multiple regulatory interactions with both the FDA and the EMA, particularly in regard to pediatric regulation. Prior to joining Lysogene, Sophie Olivier was Chief Medical Officer at Genticel. Before joining Genticel, Sophie Olivier worked as Scientific Officer, Pediatric Team, at the European Medicines Agency in London. Previously, Sophie Olivier led clinical development in Women’s Health diseases at Wyeth Pharmaceutical (Philadelphia Area, US). With her extensive career as a senior manager in the industry, spanning from early development to ensuring market access, Sophie Olivier brings a rich breadth of experience across a variety of therapeutic areas to Lysogene.
Research Interest
clinical development
